Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial

PURPOSE: Few evidence-based therapies are available for chronic olfactory dysfunction after COVID-19. This study investigated the relative efficacy of olfactory training alone, co-ultramicronized palmitoylethanolamide with luteolin (um-PEA–LUT, an anti-neuroinflammatory supplement) alone, or combine...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Stadio, Arianna, Gallina, Salvatore, Cocuzza, Salvatore, De Luca, Pietro, Ingrassia, Angelo, Oliva, Simone, Sireci, Federico, Camaioni, Angelo, Ferreli, Fabio, Mercante, Giuseppe, Gaino, Francesca, Pace, Gian Marco, La Mantia, Ignazio, Brenner, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Rhinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562315/
https://www.ncbi.nlm.nih.gov/pubmed/37380908
http://dx.doi.org/10.1007/s00405-023-08085-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562315/
https://www.ncbi.nlm.nih.gov/pubmed/37380908
http://dx.doi.org/10.1007/s00405-023-08085-8

Ejemplares similares